| Indicators | Browse All

Cingulate Inc. (CINGW)

Kansas City, United States | NasdaqCM
0.02 USD +0.00 (6.881%) ⇧ (July 13, 2026, 3:50 p.m. EDT)

Short-term:★★☆☆☆Long-term:⯪☆☆☆☆Dividends:☆☆☆☆☆
Hot Take | July 11, 2026, 6:22 a.m. EDT

The immediate outlook is severely clouded by a massive 20% reverse stock split initiated to preserve a Nasdaq listing, signaling extreme distress and a desperate attempt to meet minimum price requirements rather than organic growth. This mechanical adjustment often precedes significant volatility and dilution, making a near-term bullish entry highly speculative. Looking further ahead, the business fundamentals are catastrophic: the company is burning through cash with negative operating and free cash flows, posting double-digit negative returns on both assets and equity, and carrying a massive debt load relative to its tiny equity base. The price-to-book ratio is mathematically distorted by the reverse split and negative earnings, rendering traditional valuation metrics useless. With no dividend history and a trajectory defined by continuous capital destruction, this security represents a value trap where the market has correctly priced in the likelihood of insolvency or delisting. The statistical forecasting model suggests a potential 20% gain over the next 45 days, but given the 'very low' confidence rating and the chaotic nature of penny stocks undergoing reverse splits, this signal is noise rather than a predictive edge. Investors should avoid this instrument entirely.

None
Attribute Value
Debt to Equity Ratio 39.38
Beta -0.92
Website https://www.cingulate.com

Info Dump

Attribute Value
Address1 1,901 West 47th Place
Ask 0.0
Ask Size 0
Beta -0.915
Bid 0.0
Bid Size 0
Book Value 1.584
City Kansas City
Compensation As Of Epoch Date 1,767,139,200
Country United States
Crypto Tradeable 0
Currency USD
Current Price 0.0233
Current Ratio 2.547
Custom Price Alert Confidence HIGH
Day High 0.0233
Day Low 0.0233
Debt To Equity 39.38
Display Name Cingulate
Ebitda -23,658,508
Ebitda Margins 0.0
Eps Trailing Twelve Months -1.732
Esg Populated 0
Exchange NCM
Exchange Data Delayed By 0
Exchange Timezone Name America/New_York
Exchange Timezone Short Name EDT
Fifty Two Week High 0.0233
Fifty Two Week High Change 0.0
Fifty Two Week High Change Percent 0.0
Fifty Two Week Low 0.0233
Fifty Two Week Low Change 0.0
Fifty Two Week Low Change Percent 0.0
Fifty Two Week Range 0.0233 - 0.0233
Financial Currency USD
First Trade Date Milliseconds 1,783,690,200,000
Float Shares 12,944,387
Free Cashflow -11,919,704
Full Exchange Name NasdaqCM
Full Time Employees 14
Gmt Off Set Milliseconds -14,400,000
Gross Margins 0.0
Gross Profits -9,735,749
Has Pre Post Market Data 1
Industry
Industry Key
Ipo Expected Date 2,021-12-08
Language en-US
Long Business Summary Cingulate Inc., a biopharmaceutical company, develops pharmaceutical products using its drug delivery platform technology for the treatment of attention deficit/hyperactivity disorder (ADHD) and anxiety in the United States. The company's lead product candidate is CTx-1301 (dexmethylphenidate), which is in Phase 3 clinical trials for the treatment of ADHD in children, adolescents, and adults. It also develops CTx-2103 (buspirone), which is in a formulation stage for the treatment of anxiety. In addition, the company plans to initiate a clinical plan for CTx-1302 (dextroamphetamine) to treat ADHD. Cingulate Inc. was founded in 2012 and is headquartered in Kansas City, Kansas.
Long Name Cingulate Inc.
Market us_market
Market State POSTPOST
Max Age 86,400
Message Board Id finmb_1674914781
Net Income To Common -27,909,322
Open 0.0385
Operating Cashflow -19,549,860
Operating Margins 0.0
Phone 913 942 2300
Previous Close 0.0218
Price Hint 4
Price To Book 0.014709596
Profit Margins 0.0
Quick Ratio 2.373
Quote Source Name Delayed Quote
Quote Type EQUITY
Recommendation Key none
Region US
Regular Market Change 0.0014999993
Regular Market Change Percent 6.8807306
Regular Market Day High 0.0233
Regular Market Day Low 0.0233
Regular Market Day Range 0.0233 - 0.0233
Regular Market Open 0.0385
Regular Market Previous Close 0.0218
Regular Market Price 0.0233
Regular Market Time 1,783,972,251
Regular Market Volume 2,400
Return On Assets -0.69682
Return On Equity -2.2511399
Sand P52 Week Change 0.20847368
Sector
Sector Key
Short Name Cingulate Inc. Warrants
Source Interval 15
State KS
Symbol CINGW
Total Cash 25,893,210
Total Cash Per Share 1.95
Total Debt 7,428,991
Tradeable 0
Trailing Annual Dividend Rate 0.0
Trailing Annual Dividend Yield 0.0
Trailing Eps -1.732
Trailing Peg Ratio None
Triggerable 1
Type Disp Equity
Volume 2,400
Website https://www.cingulate.com
Zip 66,205